The results are also comparable with a recently published real-world observational study from central Eastern Europe suggesting the similar effectiveness of 1L PD-1/PD-L1 with or without chemotherapy in patients with advanced NSCLC to those observed in randomized clinical trials (42). This evidence concerns the gene CD274 and non-small cell lung carcinoma.